FIELD: medicine.
SUBSTANCE: invention is related to composition with high tuberculostatic activity.
EFFECT: reduced toxicity and by-effects of its components.
1 cl, 1 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION WITH ANTI-TUBERCULOSIS EFFECT | 2006 |
|
RU2332216C2 |
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
| COMBINED ANTI-TUBERCULOSIS PREPARATION | 2007 |
|
RU2354378C1 |
| COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
| ANTI-TUBERCULOSIS MEDICATION BASED ON 4-THIOUREIDOIMINOMETHYLPYRIDINIUM PERCHLORATE, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2010 |
|
RU2423977C1 |
| COMBINED ANTITUBERCULAR PREPARATION AND METHOD FOR ITS OBTAINING | 2001 |
|
RU2182483C1 |
| COMPOSITE FORMULATION WITH ANTITUBERCULOUS ACTIVITY | 2003 |
|
RU2247560C1 |
| METHOD OF PREPARING MEDICINAL FORM OF ISONIAZIDE SHOWING DECREASED HEPATOTOXICITY | 1999 |
|
RU2153878C1 |
| COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
| COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
Authors
Dates
2010-03-20—Published
2008-04-15—Filed